Gene Therapy on Cardiovascular Disease Market to Reach USD 58.5 Billion by 2034 | CAGR 80.2% According to a report by Intel Market Research, global Gene Therapy on Cardiovascular Disease Market was valued at approximately USD 292 million in 2025 and is estimated to reach USD 526 million in 2026. The market is projected to expand to USD 58.5 billion by 2034, representing an 80.2% CAGR during 2026–2034. North America held the largest regional position in 2025. Explore the full report: https://www.intelmarketresearch.com/gene-therapy-on-cardiovascular-disease-market-market-11659